Alan F. Denenberg

Davis Polk advised the joint book-running managers and representatives of the underwriters in the approximately $42.2 million initial public offering by ASLAN Pharmaceuticals Limited…

Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Five9, Inc. of an aggregate principal amount of …

Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 5,000,000 shares of common stock of Unity Biotechnology, Inc. Unity…

Davis Polk advised the joint book-running managers in connection with the $302.5 million public offering of 11,000,000 shares of Class A common stock of Carvana Co. The Class A common…

Davis Polk is advising McKesson Corporation on its acquisition of Medical Specialties Distributors, LLC from New Mountain Capital. The transaction is valued at $800 million, and is subject…

Davis Polk advised Pivotal Software, Inc. on its SEC-registered initial public offering of 42,550,000 shares of Class A common stock, including the full exercise by the underwriters of…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by Salesforce.com, Inc. of $1 billion aggregate principal amount of its 3.250%…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Pure Storage, Inc. of $500 million aggregate principal amount of its 0.125%…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Accelerate Diagnostics, Inc. of $150 million aggregate principal amount of its 2…

Davis Polk advised Equinix, Inc. on its SEC-registered offering of €750 million aggregate principal amount of 2.875% senior notes due 2024. Equinix, Inc. connects more than 9,800 companies…